ExodusPoint Capital Management, LP
Position in LXEO — Lexeo Therapeutics, Inc.
CIK 1736225
NEW YORK, NY
Position in LXEO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$129,781
-$514,086 QoQ
Shares Held
27,880
-75.1% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 141 holders
Holding Since
Dec 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names. LXEO ranks #92 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in LXEO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $129,781 | 27,880 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $643,867 | 112,172 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $181,803 | 27,380 | Shares | Sole | 2025-11-14 | |
| 2023-12-31 | $458,588 | 34,172 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||